Vusolimogene Oderparepvec (VO) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: RP1

Filter by location:

San Francisco, California1 trial

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

University of California, San Francisco

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.